Revista da Sociedade Brasileira de Medicina Tropical (Apr 2016)

Case report of vancomycin-induced pancytopenia

  • Sorab Gupta,
  • Shorabh Sharma,
  • Nandini Menon,
  • Shradha Ahuja,
  • Michelle Dahdouh

DOI
https://doi.org/10.1590/0037-8682-0263-2015
Journal volume & issue
Vol. 49, no. 2
pp. 258 – 259

Abstract

Read online

Abstract: Vancomycin is the first-line agent for the treatment of bacteremia, endocarditis, pneumonia, cellulitis, and osteomyelitis. Pancytopenia is an uncommon adverse effect of vancomycin therapy, with only a few cases of vancomycin-related neutropenia and pancytopenia described in the literature. We describe a case of a 56-year-old man who was diagnosed with chronic paraspinal abscess and started on intravenous vancomycin. He was re-admitted two weeks later with new-onset pancytopenia. Discontinuation of vancomycin resulted in improved cell counts. Physicians should monitor cell counts in patients who are on long-term intravenous vancomycin.

Keywords